4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001144204-10-001028
10% owner bought 777,992 shares at an average $0.69 ($534,337)
- 10% owner disposed of 1,323,467 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Trinad Capital Master Fund Ltd. 10% owner | 2009-11-12 | Purchase | +11,100 | $0.85 | $9,435 | 2,349,370 | D |
| Trinad Capital Master Fund Ltd. 10% owner | 2009-11-13 | Purchase | +50,000 | $0.86 | $42,920 | 2,399,370 | D |
| Trinad Capital Master Fund Ltd. 10% owner | 2009-11-16 | Purchase | +50,500 | $0.85 | $42,925 | 2,449,870 | D |
| Trinad Capital Master Fund Ltd. 10% owner | 2009-11-19 | Purchase | +25,000 | $0.85 | $21,250 | 2,474,870 | D |
| Trinad Capital Master Fund Ltd. 10% owner | 2009-12-08 | Purchase | +86,386 | $0.66 | $56,989 | 2,561,256 | D |
| Trinad Capital Master Fund Ltd. 10% owner | 2009-12-09 | Purchase | +21,947 | $0.67 | $14,704 | 2,583,203 | D |
| Trinad Capital Master Fund Ltd. 10% owner | 2009-12-14 | Purchase | +527,683 | $0.65 | $342,888 | 3,110,886 | D |
| Trinad Capital Master Fund Ltd. 10% owner | 2009-12-21 | Purchase | +5,376 | $0.60 | $3,226 | 3,116,262 | D |
| Trinad Capital Master Fund Ltd. 10% owner | 2010-01-06 | Other disposition | −1,323,467 | 1,792,695 | D | ||
| Open-market purchases · 777,992 sh · avg $0.69 · $534,337 | |||||||
Loading xslF345X03/v170882_ex.xml…